Moneycontrol PRO
HomeNewsAshwini choubey

Ashwini Choubey

Jump to
  • Need to change Covaxin composition not felt yet due to vaccine's good efficacy against mutant variants: Govt

    Continuous monitoring of evolution of mutations is being done by the Indian SARS- CoV-2 Genomics Surveillance Consortium (INSACOG), Minister of State for Health Ashwini Choubey said.

  • Creation of health ID under NDHM not mandatory for citizens: Ashwini Choubey

    Upon opting to create a health ID, only basic demographic and geographic information of the beneficiary like name, year of birth, gender, mobile number and address are collected.

  • More than 50 lakh healthcare, frontline workers given COVID-19 vaccine in 21 days: Govt

    Responding to a question on vaccine hesitancy, he said at the start of COVID-19 vaccination drive, fewer than planned beneficiaries attended the vaccination sessions due to transient technical issues in CoWIN portal, vaccine hesitancy, among others, which have progressively been addressed.

  • Aadhaar not mandatory for registration on Co-Win portal: Union MoS Health Choubey

    On whether Aadhaar is mandatory for registering on the Co-WIN application, Choubey, in a written reply, said, 'No, Aadhaar is not mandatory for registration on Co-WIN portal.'

  • Pandemics caused by new virus infect humans in multiple waves: Govt

    Government of India has accordingly advised states to upgrade health infrastructure based on the case growth trajectory in respective states and districts, besides taking stringent containment measures, Minister of State for Health Ashwini Choubey said in a written reply.

  • 'Excellent safety' of 2 indigenous COVID-19 candidate vaccines revealed during Phase-I trials: Minister Ashwini Choubey

    Other companies in India involved in COVID-19 vaccine development are Premas Biotech, Gennova, Mynvax, Epygen Biotech, Luxmatra Innovations, Biological Evans. All candidates are in preclinical development stages, the minister said.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347